Mason company expands mental health medication services
GeneSight, a Mason-based company specializing in mental health medication, expanded its wellness services in the community.
Former Sound United Business Could Be “Discontinued” Next Year After Falling Revenues, No Buyer and Losses Claims New Director
Masimo executives are back calling their consumer audio business Sound United, with a senior executive on a conference call ...
Fierce Healthcare2d
General Catalyst's HATCo moves forward on $485M Summa Health deal
Venture capital firm General Catalyst's Health Assurance Transformation Corporation (HATCo) signed a definitive agreement to ...
Fintel on MSN3d
Raymond James Upgrades Masimo (MASI)
Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...
medtechdive3d
Masimo, amid leadership transition, targets cost reductions
Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...
Masimo (MASI) Gets a Hold from Needham
Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...
BTIG Sticks to Their Buy Rating for Masimo (MASI)
In a report released today, Marie Thibault from BTIG maintained a Buy rating on Masimo (MASI – Research Report), with a price target of ...
MassDevice4d
Masimo stock rises on Street-beating Q3, raised EPS guidance
Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...
Zacks.com on MSN4d
MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands
Masimo Corporation MASI delivered adjusted earnings per share (EPS) of 98 cents in the third quarter of 2024, up 30.7% year over year. The figure beat the Zacks Consensus Estimate by 16.7%. The ...